A look at last year’s agenda:

We're starting to put together next year's event. If you’d like to get involved or share your insight to help shape the key themes and topics, please get in touch at: jmackintosh@eyeforpharma.com

Day One

  • KEYNOTE Real-world harmony
    09:00-09:05
    Opening Address
    09:05-09:35
    Work cross-functionally to unlock new insight throughout the lifecycle
    • Adopt a cross-functional approach, enabling increased real-world understanding from discovery to post-approval
    • Understand how different teams can work together to break data silos, enhancing the internal spread of knowledge
    • Meet increasing regulatory requirements by engraining a continuous cycle of evidence generation into your company’s core efforts
    09:35-10:05
    Insights, Ecosystems, and Outcomes: Using Data to Drive Value Based, Personalised Healthcare
    • Understand how the healthcare ecosystem is undergoing an unprecedented period of change
    • Explore how life science organisations are investing in end to end evidence approaches which require new operating models and technology choices
    • Industry Case Study - Implementing an enterprise wide RWE strategy
    10:05-10:30
    Make sure your product is launch ready by integrating market access into drug development
    • Use payer insights to tailor clinical trial design to ensure the data collected meets market requirements
    • How to promote market access priorities in phase II and III to ensure a seamless, HTA-ready launch
    • Explore ways to engage payers early in order to evade potential pitfalls and hurdles to reimbursement
    10:30-10:55
    COFFEE BREAK
    10:55-11:35
    Emerging data sources - meet evolving data needs with the latest innovations
    • Discover the increased patient insight offered by previously under-utilised data sources
    • Meet increased HTA/payer demands with increased value demonstration
    • Learn how to maximise analytical capabilities by harmonising data collection across multiple platforms
    11:35-12:00
    Increase product launch success with a cross-functional use of real world evidence
    • Prepare for future product development and launch by integrating RWE across functions (Clinical Development, Medical, Market Access, Marketing).
    • Enhance product understanding and communication with a fluid approach.
    • Case example of innovative basal insulin launched in crowded diabetes market place and price containment context.
    12:00-12:25
    External collaboration with stakeholders to optimize patients access strategies “from clinical development to patient access"
    • Understand the principles of market access and medical teaming up to shape Patient’s outcomes in unmet haematological malignancies
    • Hear how R&D innovation is being accelerated through the nurturing of a ground breaking public-private relationship
    • Genuinely maximise your real-world capability by building your strategy in partnership key stakeholders and competitors
    12:25-12:50
    Driving Market Access with RWE: Rhetoric vs. Reality
    • Explore the different perceptions surrounding RWE and optimise you realworld access strategy with greater understanding of the other halves’ needs
    • Interactive session gauging the audience’s own perceptions on the Market Access- RWE relationship
    12:50-14:00
    Lunch
    14:00-14:30
    Ensure a best-in-class value dossier by harmonising clinical and commercial priorities

    Understand the benefits of putting market access at the heart of your company culture and focus all departments on the goal of reimbursement

    • Break silos: create a highly integrated cross-functional internal structure to ensure the voice of market access is represented right through the lifecycle
    • Learn how market access teams can be the bridge between pre-launch strategy and post-launch commercial teams
    14:30-15:00
    Assessing the Value of Immuno-Oncology: Challenges & Opportunities
    • What is I-O and what makes it different for payers
    • Challenges from Payers on assessing I-O
    • How assessment of I-O should evolve to capture the full value for patients
    15:00-15:30
    Understand the benefits of putting market access at the heart of your company culture
    • How to create a culture that focuses all departments on the ultimate goal of reimbursement
    • Determine the optimum role for market access leaders and learn how to manage different departmental priorities
    • Master the principles of change management to push for a large-scale reorientation of efforts and resources across the lifecycle
    15:30-16:00
    COFFEE BREAK
    16:00-16:30
    The Pharma-Payer relationship: how will it evolve and how will you change your approach?
    • Examine how attitudes and our ability to share risk has changed and determine whether payer demands will continue to grow higher
    • Behind the headlines: how can pharma avoid future pricing scandals, restore your reputation yet still achieve commercial success?
    • See how collaboration and risk-sharing will develop over the next few years – and what you need to do about it
    16:30- 17:00
    Pressure on Prices - Dealing with a Shifting Landscape

    With the continually changing priorities and challenges in healthcare, payers are adjusting their policies and processes accordingly. Global demands such as earlier access to treatments and high-cost gene therapies have resulted in increased pressure on drug prices and innovative new purchasing options being considered. This presentation will address:

    • How payers and politicians are squeezing drug costs globally while wanting quicker access
    • What the future cost pressures will be and how payers/politicians will react to them
    • How manufacturers can position themselves to maximize their opportunities of success
    17:00- 17:30
    Explore how innovative financing schemes can help you overcome payer budget restrictions
    • Be bold: How payers and pharma collaborate to ensure patients access through bold risk-sharing agreements
    • Performance-based vs. financed based: how to decide the best risksharing agreement for your product.
    • Understand the benefits to your product launch and reimbursement by investing in a risk-sharing agreement
    17:30
    Networking drinks

Day Two

  • 12:15-13:15 Choose between the following 3 workshops
    Choice 1
    Interactive Workshop 1: The role of digital technology in RWD programs
    • Explore the use of technology to support patient data capture across observational, pragmatic and commercial health management programs
    • Build in representativeness through use of patient’s own devices
    • Understand how this approach facilitates the capture of high quality, regulatory compliant datasets built for analysis and mining in a real-world setting
    • Discuss how, where applicable, technology can support enhanced patient engagement and improved health outcomes
    Choice 2
    Interactive Workshop 2: Market Access - Back to The Future
    • In this interactive workshop, we will explore Market Access Reality vs Market Access Ideology, to test the hypothesis that:
    • “To improve post-launch market access success, market access activities must start early in a product’s lifecycle”
    • If the current reality is suboptimal, what opportunities are we missing?
    • If we could go back in time and change what was done, could things have been different - could the challenges have been predicted and addressed?
    Choice 3
    Interactive Workshop 3: Maximizing real world data with governance in a digital world
    • Gain insights into managing RWD with effective governance to help create tailored programs. This workshop will help you learn how to future proof your data with best practices (acquiring, qualifying and maximizing RWD)
    • Understand the challenges of acquiring data with a real-life case study of how pharma organizations are filling the gaps on their own compliance practices
    • Explore how RWD can be used to create an effective patient/HCP journey and analyse the campaign performance

Day One

  • KEYNOTE Real-world harmony
    09:00-09:05
    Opening Address
    09:05-09:35
    Work cross-functionally to unlock new insight throughout the lifecycle
    • Adopt a cross-functional approach, enabling increased real-world understanding from discovery to post-approval
    • Understand how different teams can work together to break data silos, enhancing the internal spread of knowledge
    • Meet increasing regulatory requirements by engraining a continuous cycle of evidence generation into your company’s core efforts
    09:35-10:05
    Insights, Ecosystems, and Outcomes: Using Data to Drive Value Based, Personalised Healthcare
    • Understand how the healthcare ecosystem is undergoing an unprecedented period of change
    • Explore how life science organisations are investing in end to end evidence approaches which require new operating models and technology choices
    • Industry Case Study - Implementing an enterprise wide RWE strategy
    10:05-10:30
    Make sure your product is launch ready by integrating market access into drug development
    • Use payer insights to tailor clinical trial design to ensure the data collected meets market requirements
    • How to promote market access priorities in phase II and III to ensure a seamless, HTA-ready launch
    • Explore ways to engage payers early in order to evade potential pitfalls and hurdles to reimbursement
    10:30-10:55
    COFFEE BREAK
    10:55-11:35
    Emerging data sources - meet evolving data needs with the latest innovations
    • Discover the increased patient insight offered by previously under-utilised data sources
    • Meet increased HTA/payer demands with increased value demonstration
    • Learn how to maximise analytical capabilities by harmonising data collection across multiple platforms
    11:35-12:00
    Increase product launch success with a cross-functional use of real world evidence
    • Prepare for future product development and launch by integrating RWE across functions (Clinical Development, Medical, Market Access, Marketing).
    • Enhance product understanding and communication with a fluid approach.
    • Case example of innovative basal insulin launched in crowded diabetes market place and price containment context.
    12:00-12:25
    External collaboration with stakeholders to optimize patients access strategies “from clinical development to patient access"
    • Understand the principles of market access and medical teaming up to shape Patient’s outcomes in unmet haematological malignancies
    • Hear how R&D innovation is being accelerated through the nurturing of a ground breaking public-private relationship
    • Genuinely maximise your real-world capability by building your strategy in partnership key stakeholders and competitors
    12:25-12:50
    Driving Market Access with RWE: Rhetoric vs. Reality
    • Explore the different perceptions surrounding RWE and optimise you realworld access strategy with greater understanding of the other halves’ needs
    • Interactive session gauging the audience’s own perceptions on the Market Access- RWE relationship
    12:50-14:00
    Lunch
    14:00-14:30
    Ensure a best-in-class value dossier by harmonising clinical and commercial priorities

    Understand the benefits of putting market access at the heart of your company culture and focus all departments on the goal of reimbursement

    • Break silos: create a highly integrated cross-functional internal structure to ensure the voice of market access is represented right through the lifecycle
    • Learn how market access teams can be the bridge between pre-launch strategy and post-launch commercial teams
    14:30-15:00
    Assessing the Value of Immuno-Oncology: Challenges & Opportunities
    • What is I-O and what makes it different for payers
    • Challenges from Payers on assessing I-O
    • How assessment of I-O should evolve to capture the full value for patients
    15:00-15:30
    Understand the benefits of putting market access at the heart of your company culture
    • How to create a culture that focuses all departments on the ultimate goal of reimbursement
    • Determine the optimum role for market access leaders and learn how to manage different departmental priorities
    • Master the principles of change management to push for a large-scale reorientation of efforts and resources across the lifecycle
    15:30-16:00
    COFFEE BREAK
    16:00-16:30
    The Pharma-Payer relationship: how will it evolve and how will you change your approach?
    • Examine how attitudes and our ability to share risk has changed and determine whether payer demands will continue to grow higher
    • Behind the headlines: how can pharma avoid future pricing scandals, restore your reputation yet still achieve commercial success?
    • See how collaboration and risk-sharing will develop over the next few years – and what you need to do about it
    16:30- 17:00
    Pressure on Prices - Dealing with a Shifting Landscape

    With the continually changing priorities and challenges in healthcare, payers are adjusting their policies and processes accordingly. Global demands such as earlier access to treatments and high-cost gene therapies have resulted in increased pressure on drug prices and innovative new purchasing options being considered. This presentation will address:

    • How payers and politicians are squeezing drug costs globally while wanting quicker access
    • What the future cost pressures will be and how payers/politicians will react to them
    • How manufacturers can position themselves to maximize their opportunities of success
    17:00- 17:30
    Explore how innovative financing schemes can help you overcome payer budget restrictions
    • Be bold: How payers and pharma collaborate to ensure patients access through bold risk-sharing agreements
    • Performance-based vs. financed based: how to decide the best risksharing agreement for your product.
    • Understand the benefits to your product launch and reimbursement by investing in a risk-sharing agreement
    17:30
    Networking drinks

Day Two

  • 12:15-13:15 Choose between the following 3 workshops
    Choice 1
    Interactive Workshop 1: The role of digital technology in RWD programs
    • Explore the use of technology to support patient data capture across observational, pragmatic and commercial health management programs
    • Build in representativeness through use of patient’s own devices
    • Understand how this approach facilitates the capture of high quality, regulatory compliant datasets built for analysis and mining in a real-world setting
    • Discuss how, where applicable, technology can support enhanced patient engagement and improved health outcomes
    Choice 2
    Interactive Workshop 2: Market Access - Back to The Future
    • In this interactive workshop, we will explore Market Access Reality vs Market Access Ideology, to test the hypothesis that:
    • “To improve post-launch market access success, market access activities must start early in a product’s lifecycle”
    • If the current reality is suboptimal, what opportunities are we missing?
    • If we could go back in time and change what was done, could things have been different - could the challenges have been predicted and addressed?
    Choice 3
    Interactive Workshop 3: Maximizing real world data with governance in a digital world
    • Gain insights into managing RWD with effective governance to help create tailored programs. This workshop will help you learn how to future proof your data with best practices (acquiring, qualifying and maximizing RWD)
    • Understand the challenges of acquiring data with a real-life case study of how pharma organizations are filling the gaps on their own compliance practices
    • Explore how RWD can be used to create an effective patient/HCP journey and analyse the campaign performance

Got any questions or interested in what’s in store for 2018? Get in touch below.

James Mackintosh

James Mackintosh

Global Project Director
eyeforpharma
+1800 814 3459 x7163 (US)
+44 (0) 207 375 7163 (Global)
Email: jmackintosh@eyeforpharma.com

2017 Sponsors & Exhibitors

Gold Sponsors

  • Covance
  • Deloitte
  • Epsilon
  • Evidera
  • Highpoint Solutions
  • Quintiles IMS

Silver Sponsors

  • IGES
  • VALID

Supporting Sponsor

  • Caligor